Page last updated: 2024-09-04

torcetrapib and Electrolytes

torcetrapib has been researched along with Electrolytes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arca, M; Asselbergs, FW; Boekholdt, SM; Cambien, F; Casas, JP; Cooper, J; D'Agostino, RB; Deanfield, J; Dullaart, RP; Ebrahim, S; Ford, I; Freeman, D; Gaudio, C; Goto, A; Gudnason, V; Hingorani, AD; Horne, BD; Humphries, SE; Isaacs, A; Kakko, S; Kastelein, JJ; Kauma, H; Kesäniemi, YA; Khaw, KT; Kivimaki, M; Kumari, M; Lawlor, DA; Li, TY; Marmot, M; McCaskie, P; McCormack, V; Navis, G; Nicaud, V; Okumura, K; Ordovas, J; Packard, C; Palmer, LJ; Paulweber, B; Pencina, M; Poirer, O; Quagliarini, F; Ricketts, SL; Sandhofer, A; Sandhu, MS; Sattar, N; Savolainen, MJ; Shah, T; Smeeth, L; Smith, GD; Sofat, R; Sorli, JV; Talmud, PJ; Thompson, JF; van der Harst, P; van Duijn, CM; Van Gilst, WH; van Veldhuisen, DJ; Vasan, RS; Wareham, N; Witteman, JC; Yokoyama, S1

Other Studies

1 other study(ies) available for torcetrapib and Electrolytes

ArticleYear
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms.
    Circulation, 2010, Jan-05, Volume: 121, Issue:1

    Topics: Anticholesteremic Agents; Biomarkers; Blood Pressure; Cholesterol Ester Transfer Proteins; Dose-Response Relationship, Drug; Electrolytes; Genotype; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, HDL; Polymorphism, Single Nucleotide; Quinolines; Randomized Controlled Trials as Topic; Risk Factors; White People

2010